Therapeutic Response to Lansoprazole Among Different Subgroups of Functional Dyspepsia: a Multicenter, Randomized, Double-blind, Placebo-controlled Trial.
Phase of Trial: Phase IV
Latest Information Update: 06 Jun 2014
At a glance
- Drugs Lansoprazole (Primary)
- Indications Dyspepsia
- Focus Therapeutic Use
- 14 Apr 2014 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 12 Aug 2013 Planned end date changed from 1 Mar 2011 to 1 Dec 2013 as reported by ClinicalTrials.gov.
- 16 Mar 2010 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.